Researchers from Tokyo Metropolitan University have found that the motion of unlabeled cells can be used to tell whether they are cancerous or healthy. They observed malignant fibrosarcoma cells and healthy fibroblasts on a dish and found that tracking and analysis of their paths can be used to differentiate them with up to 94% accuracy. Beyond diagnosis, their technique may also shed light on cell motility related functions, like tissue healing.
While scientists and medical experts have been looking at cells under the microscope for many centuries, most studies and diagnoses focus on their shape, what they contain, and where different parts are located inside. But cells are dynamic, changing over time, and are known to be able to move. By accurately tracking and analyzing their motion, we may be able to differentiate cells which have functions relying on cell migration. An important example is cancer metastasis, where the motility of cancerous cells allows them to spread.
However, this is easier said than done. For one, studying a small subset of cells can give biased results. Any accurate diagnostic technique would rely on automated, high-throughput tracking of a significant number of cells. Many methods then turn to fluorescent labeling, which makes cells much easier to see under the microscope. But this labeling procedure can itself affect their properties. The ultimate goal is an automated method which uses label-free conventional microscopy to characterize cell motility and show whether cells are healthy or not.
Now, a team of researchers from Tokyo Metropolitan University led by Professor Hiromi Miyoshi have come up with a way of tracking cells using phase-contrast microscopy, one of the most common ways of observing cells. Phase-contrast microscopy is entirely label free, allowing cells to move about on a petri dish closer to their native state, and is not affected by the optical properties of the plastic petri dishes through which cells are imaged. Through innovative image analysis, they were able to extract trajectories of many individual cells. They focused on properties of the paths taken, like migration speed, and how curvy the paths were, all of which would encode subtle differences in deformation and movement.
As a test, they compared healthy fibroblast cells, the key component of animal tissue, and malignant fibrosarcoma cells, cancerous cells which derive from fibrous connective tissue. They were able to show that the cells migrated in subtly different ways, as characterized by the “sum of turn angles” (how curvy the paths were), the frequency of shallow turns, and how quickly they moved. In fact, by combining both the sum of turn angles and how often they made shallow turns, they could predict whether a cell was cancerous or not with an accuracy of 94%.
The team’s work not only promises a new way to discriminate cancer cells, but applications to research of any biological function based on cell motility, like the healing of wounds and tissue growth.
This work was supported by JSPS KAKENHI Grant Number JP24K01998, Tokyo Metropolitan Government Advanced Research Grant Number R2-2, and the TMU Strategic Research Fund for Social Engagement.
Endo, S., et al. (2025). Development of label-free cell tracking for discrimination of the heterogeneous mesenchymal migration. PLoS ONE. doi.org/10.1371/journal.pone.0320287.
Image Credit:
[/fusion_text][/fusion_builder_column][/fusion_builder_row]
[/fusion_builder_container]News
This Deadly Disease Was Wiping Out Humans 5,500 Years Ago
A new study suggests plague was already a deadly threat 5,500 years ago, striking small hunter-gatherer communities long before cities and agriculture emerged. For centuries, plague has been remembered as the disease that devastated [...]
China closing in but US leads in biotech quality, commercial reach, survey finds
SAN DIEGO, June 22 (Reuters) - China, which now conducts more clinical drug trials, opens new tab than the U.S., still lags in the quality and commercial reach of its biomedical science, according to a recent survey, opens new [...]
New method generates renewable supply of progenitor immune cells
In a paper published in Cell, a USC Stem Cell-led team reports a new way of generating a renewable and expandable supply of the progenitor cells that give rise to macrophages. These immune cells help [...]
Scientists Just Discovered a Cellular Survival System That Was Never Supposed To Exist
A surprising backup pathway allows cells to make a crucial amino acid when their primary machinery fails. For decades, biologists believed cells had only one way to access a molecule they cannot live without. New [...]
Artificial cells gain porous membranes, enabling lab reactions and drug release
Artificial cells created in the laboratory offer a wide range of potential applications. Until now, however, their membranes—unlike those of real cells—have been virtually impermeable. Researchers at the Max Planck Institute for Polymer Research, [...]
Popular Weight-Loss Drugs Like Ozempic Linked to Lower Breast Cancer Risk
Ozempic and similar weight-loss drugs were linked to a striking 30% reduction in breast cancer risk in a study of more than 110,000 women. Popular weight-loss and diabetes medications such as Ozempic, Wegovy, Mounjaro, [...]
Stanford Scientists Discover Explosive New Type of Immune Cell
Scientists studying the remarkable regenerative abilities of planarian flatworms have uncovered a previously unknown type of immune cell with an unusually destructive defense strategy. What if an immune cell could wipe out nearby threats [...]
Big Pharma-backed SonoThera sounds off with $125M series B for bubble-based genetic delivery
Bay Area biotech SonoThera is bubbling to a clinical boil after raising a $125 million series B with the backing of some of the biggest names in pharma. Vida Ventures led the raise, with the venture [...]
Joint initiative of 5 EU countries calls for ‘unified approach’ to pharma framework amid US drug pricing pressure
With drug pricing pressure building from the U.S., a healthcare-focused consortium of five European countries is calling for a “unified approach” to strengthen Europe’s pharmaceutical framework and access to innovative medicines. Belgium, the Netherlands, [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Molecular Manufacturing: The Future of Nanomedicine – New book from NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
NanoMedical Brain/Cloud Interface – Explorations and Implications. A new book from Frank Boehm
New book from Frank Boehm, NanoappsMedical Inc Founder: This book explores the future hypothetical possibility that the cerebral cortex of the human brain might be seamlessly, safely, and securely connected with the Cloud via [...]
New book from Nanoappsmedical Inc. – Global Health Care Equivalency
A new book by Frank Boehm, NanoappsMedical Inc. Founder. This groundbreaking volume explores the vision of a Global Health Care Equivalency (GHCE) system powered by artificial intelligence and quantum computing technologies, operating on secure [...]
UCLA Scientists Uncover a “Hidden Weakness” in Some of the World’s Deadliest Cancers
A new study has uncovered an unexpected vulnerability in some of the deadliest cancers. Researchers at UCLA have identified a previously hidden weakness in some of the most aggressive cancers, pointing to a possible new way [...]
AI-designed universal coronavirus vaccine clears first human trial
Key Takeaways Super-Antigen Technology: Uses AI and machine learning to analyze viral genomes, creating a single vaccine that targets essential features across entire virus families, including coronaviruses and Ebola. Human Trials & Safety: Phase [...]
Researchers Discover a Hidden Vitamin D Problem That Persists Year-Round
A new study suggests that some groups may not experience the expected seasonal boost in vitamin D levels, even during the sunniest months of the year. Many people assume that spending more time outdoors [...]















